MAPT and Alzheimer disease: Tryptophan metabolites, QUINA and KYNA, together with other intermediates, show elevated concentrations associated with Aβ and tau in the CSF of AD patients, which are neurodegeneration biomarkers, suggesting that TRP is closely related to the core pathology of AD [125].